Attached files
| file | filename |
|---|---|
| EX-10.10 - EXHIBIT 10.10 - BeiGene, Ltd. | exhibit1010-sharepurch.htm |
| EX-32.1 - EXHIBIT 32.1 - BeiGene, Ltd. | exhibit321-906cert.htm |
| EX-31.2 - EXHIBIT 31.2 - BeiGene, Ltd. | exhibit312-302certcfo.htm |
| EX-31.1 - EXHIBIT 31.1 - BeiGene, Ltd. | exhibit311-302certceo.htm |
| EX-23.1 - EXHIBIT 23.1 - BeiGene, Ltd. | exhibit231-auditorscon.htm |
| EX-10.6.1 - EXHIBIT 10.6.1 - BeiGene, Ltd. | exhibit1061-assignment.htm |
| EX-10.12 - EXHIBIT 10.12 - BeiGene, Ltd. | exhibit1012-beigenegua.htm |
| EX-10.11 - EXHIBIT 10.11 - BeiGene, Ltd. | exhibit1011-collaborat.htm |
| EX-10.9 - EXHIBIT 10.9 - BeiGene, Ltd. | exhibit109-sharepurcha.htm |
| EX-4.6 - EXHIBIT 4.6 - BeiGene, Ltd. | exhibit46-descriptiono.htm |
| 10-K - 10-K - BeiGene, Ltd. | bgne-2019123110k.htm |
Exhibit 21.1
Subsidiaries
Name of Subsidiary | Jurisdiction of Incorporation or Organization | Percentage of Ownership by the Registrant | |||
BeiGene 101 | Cayman Islands | 100 | % | ||
BeiGene AUS Pty Ltd. | Australia | 100 | % | ||
BeiGene (Beijing) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Biologics Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Canada) ULC | Canada | 100 | % | ||
BeiGene ESP, S.L. | Spain | 100 | % | ||
BeiGene France Sarl | France | 100 | % | ||
BeiGene Germany GmbH | Germany | 100 | % | ||
BeiGene Guangzhou Biologics Manufacturing Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Hong Kong) Co., Limited | Hong Kong | 100 | % | ||
Beijing Innerway Bio-tech Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Italy) Sarl | Italy | 100 | % | ||
BeiGene Ireland Limited | Republic of Ireland | 100 | % | ||
BeiGene Korea Y.H. | Korea | 100 | % | ||
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Pharmaceutical (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Shanghai) Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Shanghai) Research & Development Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Singapore Pte., Ltd. | Singapore | 100 | % | ||
BeiGene (Suzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Switzerland GmbH | Switzerland | 100 | % | ||
BeiGene (Taiwan) Limited | Republic of China | 100 | % | ||
BeiGene UK, Ltd. | United Kingdom | 100 | % | ||
BeiGene United Kingdom, Ltd. | United Kingdom | 100 | % | ||
BeiGene USA, Inc. | United States | 100 | % | ||
Mapkure, LLC | United States | 71 | % | ||